• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后计划性再入院的时间和原因:来自全国再入院数据库的见解。

Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.

机构信息

Keele Cardiovascular Research Group, Keele University, Stoke-on-Trent, United Kingdom; Royal Stoke University Hospital, Stoke-on-Trent, United Kingdom.

VA New York Harbor Healthcare System, New York University School of Medicine, New York, New York.

出版信息

JACC Cardiovasc Interv. 2019 Apr 22;12(8):734-748. doi: 10.1016/j.jcin.2019.02.007. Epub 2019 Mar 27.

DOI:10.1016/j.jcin.2019.02.007
PMID:30928446
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6843988/
Abstract

OBJECTIVES

The aim of this study was to describe the rates and causes of unplanned readmissions at different time periods following percutaneous coronary intervention (PCI).

BACKGROUND

The rates and causes of readmission at different time periods after PCI remain incompletely elucidated.

METHODS

Patients undergoing PCI between 2010 and 2014 in the U.S. Nationwide Readmission Database were evaluated for the rates, causes, predictors, and costs of unplanned readmission between 0 and 7 days, 8 and 30 days, 31 and 90 days, and 91 and 180 days after index discharge.

RESULTS

This analysis included 2,412,000 patients; 2.5% were readmitted between 0 and 7 days, 7.6% between 8 and 30 days, 8.9% between 31 and 90 days, and 8.0% between 91 and 180 days (cumulative rates 2.5%, 9.9%, 18.0%, and 24.8%, respectively). The majority of readmissions during each time period were due to noncardiac causes (53.1% to 59.6%). Nonspecific chest pain was the most common identifiable noncardiac cause for readmission during each time period (14.2% to 22.7% of noncardiac readmissions). Coronary artery disease including angina was the most common cardiac cause for readmission during each time period (37.4% to 39.3% of cardiac readmissions). The second most common cardiac cause for readmission was acute myocardial infarction between 0 and 7 days (27.6% of cardiac readmissions) and heart failure during all subsequent time periods (22.2% to 23.7% of cardiac readmissions).

CONCLUSIONS

Approximately 25% of patients following PCI have unplanned readmissions within 6 months. Causes of readmission depend on the timing at which they are assessed, with noncardiovascular causes becoming more important at longer time points.

摘要

目的

本研究旨在描述经皮冠状动脉介入治疗(PCI)后不同时间段内计划外再入院的发生率和原因。

背景

PCI 后不同时间段内再入院的发生率和原因仍不完全清楚。

方法

在美国全国再入院数据库中,2010 年至 2014 年间接受 PCI 的患者,评估了索引出院后 0 至 7 天、8 至 30 天、31 至 90 天和 91 至 180 天内计划外再入院的发生率、原因、预测因素和费用。

结果

本分析共纳入 241.2 万名患者;0 至 7 天内再入院率为 2.5%,8 至 30 天内再入院率为 7.6%,31 至 90 天内再入院率为 8.9%,91 至 180 天内再入院率为 8.0%(累积再入院率分别为 2.5%、9.9%、18.0%和 24.8%)。每个时间段内大多数再入院的原因是非心脏原因(53.1%至 59.6%)。非特异性胸痛是每个时间段内再入院最常见的可识别非心脏原因(非心脏再入院的 14.2%至 22.7%)。每个时间段内,冠状动脉疾病(包括心绞痛)是再入院最常见的心脏原因(心脏再入院的 37.4%至 39.3%)。第二个最常见的心脏再入院原因是 PCI 后 0 至 7 天的急性心肌梗死(心脏再入院的 27.6%)和所有后续时间段的心力衰竭(心脏再入院的 22.2%至 23.7%)。

结论

大约 25%的 PCI 后患者在 6 个月内有计划外再入院。再入院的原因取决于评估的时间点,非心血管原因在较长时间点变得更为重要。

相似文献

1
Timing and Causes of Unplanned Readmissions After Percutaneous Coronary Intervention: Insights From the Nationwide Readmission Database.经皮冠状动脉介入治疗后计划性再入院的时间和原因:来自全国再入院数据库的见解。
JACC Cardiovasc Interv. 2019 Apr 22;12(8):734-748. doi: 10.1016/j.jcin.2019.02.007. Epub 2019 Mar 27.
2
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database.美国 833344 例经皮冠状动脉介入治疗后 30 天再入院负担:预测因素、原因和费用:来自全国再入院数据库的见解。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674. doi: 10.1016/j.jcin.2018.01.248.
3
Effect of Gender on Unplanned Readmissions After Percutaneous Coronary Intervention (from the Nationwide Readmissions Database).性别对经皮冠状动脉介入治疗后非计划再入院的影响(来自全国再入院数据库)
Am J Cardiol. 2018 Apr 1;121(7):810-817. doi: 10.1016/j.amjcard.2017.12.032. Epub 2018 Jan 10.
4
Thirty-Day Readmission Rate and Costs After Percutaneous Coronary Intervention in the United States: A National Readmission Database Analysis.美国经皮冠状动脉介入治疗后的 30 天再入院率和费用:全国再入院数据库分析。
Circ Cardiovasc Interv. 2017 Dec;10(12). doi: 10.1161/CIRCINTERVENTIONS.117.005925.
5
Etiologies and predictors of 30-day readmissions in patients undergoing percutaneous mechanical circulatory support-assisted percutaneous coronary intervention in the United States: Insights from the Nationwide Readmissions Database.美国接受经皮机械循环支持辅助经皮冠状动脉介入治疗患者30天再入院的病因及预测因素:来自全国再入院数据库的见解
Clin Cardiol. 2018 Apr;41(4):450-457. doi: 10.1002/clc.22893. Epub 2018 Apr 26.
6
Thirty-Day Readmissions After Chronic Total Occlusion Percutaneous Coronary Intervention in the United States: Insights From the Nationwide Readmissions Database.美国慢性完全闭塞经皮冠状动脉介入治疗 30 天再入院率:来自全国再入院数据库的分析。
Cardiovasc Revasc Med. 2020 Aug;21(8):992-997. doi: 10.1016/j.carrev.2019.12.025. Epub 2019 Dec 26.
7
Discharge Against Medical Advice After Percutaneous Coronary Intervention in the United States.美国经皮冠状动脉介入治疗后无医嘱离院。
JACC Cardiovasc Interv. 2018 Jul 23;11(14):1354-1364. doi: 10.1016/j.jcin.2018.03.049.
8
Multiple unplanned readmissions after discharge for an admission with percutaneous coronary intervention.经皮冠状动脉介入治疗入院后出院时出现多次非计划再入院情况。
Catheter Cardiovasc Interv. 2021 Feb 15;97(3):395-408. doi: 10.1002/ccd.28797. Epub 2020 Feb 28.
9
Relation Between Age and Unplanned Readmissions After Percutaneous Coronary Intervention (Findings from the Nationwide Readmission Database).经皮冠状动脉介入治疗后年龄与非计划再入院之间的关系(来自全国再入院数据库的研究结果)
Am J Cardiol. 2018 Jul 15;122(2):220-228. doi: 10.1016/j.amjcard.2018.03.367. Epub 2018 Apr 12.
10
Etiologies, trends, and predictors of readmission in ST-elevation myocardial infarction patients undergoing multivessel percutaneous coronary intervention.ST 段抬高型心肌梗死患者行多血管经皮冠状动脉介入治疗后再入院的病因、趋势和预测因素。
Catheter Cardiovasc Interv. 2019 Dec 1;94(7):905-914. doi: 10.1002/ccd.28344. Epub 2019 Jun 4.

引用本文的文献

1
Evaluating gender-based disparities in the outcomes of impella use in acute myocardial infarction patients with cardiogenic shock; insights from real-world global data.评估急性心肌梗死合并心源性休克患者使用Impella的治疗结果中的性别差异;来自全球真实世界数据的见解。
BMC Cardiovasc Disord. 2025 Jul 28;25(1):548. doi: 10.1186/s12872-025-04999-9.
2
Rates, Causes, and Predictive Factors of Hospital Readmissions After Spine Surgery for Lumbar Spinal Stenosis: A Nationwide Retrospective Cohort Study.腰椎管狭窄症脊柱手术后再入院的发生率、原因及预测因素:一项全国性回顾性队列研究。
Neurospine. 2025 Jun;22(2):523-539. doi: 10.14245/ns.2449316.658. Epub 2025 Jun 30.
3

本文引用的文献

1
Thirty-Day Readmission Rates, Timing, Causes, and Costs after ST-Segment-Elevation Myocardial Infarction in the United States: A National Readmission Database Analysis 2010-2014.美国 ST 段抬高型心肌梗死患者 30 天再入院率、时间、原因和费用:2010-2014 年全国再入院数据库分析。
J Am Heart Assoc. 2018 Sep 18;7(18):e009863. doi: 10.1161/JAHA.118.009863.
2
Relation Between Age and Unplanned Readmissions After Percutaneous Coronary Intervention (Findings from the Nationwide Readmission Database).经皮冠状动脉介入治疗后年龄与非计划再入院之间的关系(来自全国再入院数据库的研究结果)
Am J Cardiol. 2018 Jul 15;122(2):220-228. doi: 10.1016/j.amjcard.2018.03.367. Epub 2018 Apr 12.
3
Study on the management effect of chronic disease intelligent information management platform in post percutaneous coronary intervention patients.
经皮冠状动脉介入治疗患者慢性病智能信息管理平台管理效果研究。
Technol Health Care. 2024;32(6):4475-4484. doi: 10.3233/THC-240621.
4
Readmissions After Left Atrial Appendage Closure in Patients With Previous Ischemic Stroke or Transient Ischemic Attack.既往有缺血性中风或短暂性脑缺血发作患者左心耳封堵术后的再入院情况
CJC Open. 2023 Sep 17;5(12):950-964. doi: 10.1016/j.cjco.2023.09.009. eCollection 2023 Dec.
5
Challenges and Burdens in the Coronary Artery Disease Care Pathway for Patients Undergoing Percutaneous Coronary Intervention: A Contemporary Narrative Review.经皮冠状动脉介入治疗患者的冠状动脉疾病护理路径中的挑战和负担:当代叙事性综述。
Int J Environ Res Public Health. 2023 Apr 25;20(9):5633. doi: 10.3390/ijerph20095633.
6
Early vs. Late Readmission following Percutaneous Coronary Intervention: Predictors and Impact on Long-Term Outcomes.经皮冠状动脉介入治疗后早期与晚期再入院:预测因素及对长期结局的影响
J Clin Med. 2023 Feb 20;12(4):1684. doi: 10.3390/jcm12041684.
7
Incidence and prognosis of late readmission after percutaneous coronary intervention.经皮冠状动脉介入治疗后晚期再入院的发生率和预后。
Cardiol J. 2023;30(5):696-704. doi: 10.5603/CJ.a2022.0117. Epub 2022 Dec 13.
8
The Association of Sex with Unplanned Cardiac Readmissions following Percutaneous Coronary Intervention in Australia: Results from a Multicentre Outcomes Registry (GenesisCare Cardiovascular Outcomes Registry).澳大利亚经皮冠状动脉介入治疗后非计划心脏再入院与性别的关联:多中心结局登记研究(创世纪医疗心血管结局登记研究)的结果
J Clin Med. 2022 Nov 21;11(22):6866. doi: 10.3390/jcm11226866.
9
Readmission After ACS: Burden, Epidemiology, and Mitigation.急性冠脉综合征(ACS)后再入院:负担、流行病学和缓解策略。
Curr Cardiol Rep. 2022 Jul;24(7):807-815. doi: 10.1007/s11886-022-01702-8. Epub 2022 Apr 30.
10
Understanding Patients' Intention to Use Digital Health Apps That Support Postdischarge Symptom Monitoring by Providers Among Patients With Acute Coronary Syndrome: Survey Study.了解急性冠状动脉综合征患者使用由医疗机构提供的支持出院后症状监测的数字健康应用程序的意愿:调查研究
JMIR Hum Factors. 2022 Mar 7;9(1):e34452. doi: 10.2196/34452.
Burden of 30-Day Readmissions After Percutaneous Coronary Intervention in 833,344 Patients in the United States: Predictors, Causes, and Cost: Insights From the Nationwide Readmission Database.
美国 833344 例经皮冠状动脉介入治疗后 30 天再入院负担:预测因素、原因和费用:来自全国再入院数据库的见解。
JACC Cardiovasc Interv. 2018 Apr 9;11(7):665-674. doi: 10.1016/j.jcin.2018.01.248.
4
Effect of Gender on Unplanned Readmissions After Percutaneous Coronary Intervention (from the Nationwide Readmissions Database).性别对经皮冠状动脉介入治疗后非计划再入院的影响(来自全国再入院数据库)
Am J Cardiol. 2018 Apr 1;121(7):810-817. doi: 10.1016/j.amjcard.2017.12.032. Epub 2018 Jan 10.
5
One-year rehospitalisation after percutaneous coronary intervention: a retrospective analysis.经皮冠状动脉介入治疗后一年的再住院情况:回顾性分析。
EuroIntervention. 2018 Oct 20;14(8):926-934. doi: 10.4244/EIJ-D-17-00800.
6
Review of early hospitalisation after percutaneous coronary intervention.经皮冠状动脉介入治疗后早期住院情况综述。
Int J Cardiol. 2017 Jan 15;227:370-377. doi: 10.1016/j.ijcard.2016.11.050. Epub 2016 Nov 9.
7
Clinical Interventions to Reduce Preventable Hospital Readmission After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后减少可预防的医院再入院的临床干预措施。
Circ Cardiovasc Qual Outcomes. 2016 Sep;9(5):600-4. doi: 10.1161/CIRCOUTCOMES.116.003086. Epub 2016 Aug 23.
8
Incidence, Predictors, and Impact of Post-Discharge Bleeding After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后出院后出血的发生率、预测因素和影响。
J Am Coll Cardiol. 2015 Sep 1;66(9):1036-45. doi: 10.1016/j.jacc.2015.06.1323.
9
Stroke following percutaneous coronary intervention: type-specific incidence, outcomes and determinants seen by the British Cardiovascular Intervention Society 2007-12.经皮冠状动脉介入治疗后的中风:英国心血管介入学会 2007-12 年观察到的特定类型中风的发生率、结局和决定因素。
Eur Heart J. 2015 Jul 1;36(25):1618-28. doi: 10.1093/eurheartj/ehv113. Epub 2015 Apr 20.
10
Access and non-access site bleeding after percutaneous coronary intervention and risk of subsequent mortality and major adverse cardiovascular events: systematic review and meta-analysis.经皮冠状动脉介入治疗后穿刺部位与非穿刺部位出血及后续死亡风险和主要不良心血管事件:系统评价与荟萃分析
Circ Cardiovasc Interv. 2015 Apr;8(4). doi: 10.1161/CIRCINTERVENTIONS.114.001645.